Cannabinoid Encyclopedia

Focused research review

How does THCV interact with cannabinoid targets?

What evidence connects THCV with receptor, target, metabolic, or pharmacology mechanisms?

Updated July 2026 23 research sources Mostly early-stage research

The short answer

What is the bottom line?

Research has examined THCV and cannabinoid targets. This page brings together 7 human-study sources, 6 research reviews, and 10 lab, animal, or mechanism sources. Most of the current evidence is preclinical or focused on biological mechanisms. The studies do not all test the same product, dose, group of people, or outcome, so they cannot be reduced to one answer for every person or product. 1

Choose your next step

Want the quick path or the full picture?

Use this guide the way you need to. Start with the practical question, then open the study detail only when it helps answer something about THCV and cannabinoid targets.

What researchers studiedSee the main areas and the evidence behind each one. Safety and limitsKeep product, dose, medications, and context in view. Open the sourcesGo directly to the studies and references used here.

Key takeaways

What to know first

  1. 1

    Research on THCV and cannabinoid targets covers Receptor, target, metabolic, or pharmacology mechanisms; those areas should not be combined into one claim. 1

  2. 2

    Most of the current evidence is preclinical or focused on biological mechanisms. 2

  3. 3

    Dose, formulation, route, study population, and outcome can change how closely a study applies to a real-world question. 3

Research areas

What researchers studied about THCV and cannabinoid targets

These are the main questions represented in the current literature. Each link opens a source used to build the overview.

Mostly mechanism-focused

Receptor, target, metabolic, or pharmacology mechanisms

This part of the literature focuses on Receptor, target, metabolic, or pharmacology mechanisms. Studies may use different compounds, formulations, doses, routes, groups of people, and outcomes, so the details of each source matter. 2

How strong is the research?

Not every study answers the same question

This page separates research in people, research reviews, and earlier-stage biology before interpreting the larger question.

7 sources

Human studies

Research involving people is closest to everyday health questions. The product, dose, population, and outcome still determine what each study can show.

6 sources

Reviews and evidence summaries

Reviews can compare several studies at once. Their conclusion is only as strong and as relevant as the studies they include.

10 sources

Lab, animal, and mechanism research

Early-stage research can explain biological interest. It cannot, by itself, show that the same effect happens in people.

What these studies actually looked at

The research on THCV and cannabinoid targets is not one kind of study. This source set includes 12 animal studies, 5 narrative or expert reviews, 1 cell or laboratory study, and 1 clinical study in people. 3

The recorded populations or models include animal models (8 sources), people or patients (8 sources), and cells or tissue models (3 sources). A result from one group or model should not be assumed to apply to another. 4

The most common recorded outcome focus is receptor, target, metabolic, or pharmacology mechanisms (23 sources). Closely related outcome names can still describe different measurements. 5

The THCV and cannabinoid targets source set also contains findings or reviews that remain too limited, indirect, or mixed for a broad answer. That uncertainty is part of the result, not an empty space to fill with assumptions. 6

Examples from the literature

What did the studies actually look at?

Each example names the research question and the study details recorded for that source.

systematic review or meta-analysis

Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review.

On this page, this source examines THCV activity involving receptor, target, metabolic, or pharmacology mechanisms. 1

Study type
systematic review or meta-analysis
Population or model
cells or tissue models
Outcome focus
receptor, target, metabolic, or pharmacology mechanisms
Evidence stage
evidence still limited

cell or laboratory study

SKNY-1, a THCV Analog, Produces Weight Loss, Lipid Normalization and Attenuation of Reward-Associated Behaviors in an mc4r(G894C) Zebrafish Model of Obesity.

On this page, this source examines THCV activity involving receptor, target, metabolic, or pharmacology mechanisms. 2

Study type
cell or laboratory study
Population or model
people or patients
Outcome focus
receptor, target, metabolic, or pharmacology mechanisms
Evidence stage
mechanism-focused research

narrative or expert review

It Is Our Turn to Get Cannabis High: Put Cannabinoids in Food and Health Baskets.

On this page, this source examines THCV activity involving receptor, target, metabolic, or pharmacology mechanisms. 3

Study type
narrative or expert review
Population or model
people or patients
Outcome focus
receptor, target, metabolic, or pharmacology mechanisms
Evidence stage
evidence still limited

clinical study in people

Neural effects of cannabinoid CB1 neutral antagonist tetrahydrocannabivarin on food reward and aversion in healthy volunteers.

On this page, this source examines THCV activity involving receptor, target, metabolic, or pharmacology mechanisms. 4

Study type
clinical study in people
Outcome focus
receptor, target, metabolic, or pharmacology mechanisms
Evidence stage
mechanism-focused research

narrative or expert review

Molecular Pharmacology of Phytocannabinoids.

On this page, this source examines THCV activity involving receptor, target, metabolic, or pharmacology mechanisms. 5

Study type
narrative or expert review
Outcome focus
receptor, target, metabolic, or pharmacology mechanisms
Evidence stage
evidence still limited

Safety and limits

What should readers keep in mind?

Research on THCV and cannabinoid targets should be read beside safety. A compound can be non-intoxicating or naturally occurring and still have pharmacologic effects, side effects, interactions, or product-quality concerns. 2

Research doses are descriptions of what a study tested. They are not personal dosing instructions. Questions involving medications, pregnancy, children, driving, liver health, heart health, or serious symptoms deserve professional medical guidance.

Drug interactions Pregnancy and children Driving and impairment All safety topics

Common questions

Questions people ask

What evidence connects THCV with receptor, target, metabolic, or pharmacology mechanisms?

Relevant research is collected here. Most of the current evidence is preclinical or focused on biological mechanisms. 7

Why is there not always a yes-or-no answer?

The sources may test different products, doses, people, and outcomes, so a single conclusion can hide important differences. 8

Where can I read the original studies?

Use the numbered citations and the source list at the bottom of the page to open PubMed or DOI records. 9

Sources

Read the research

The numbered sources below support the main overview. Links open the PubMed record or DOI in a new tab.

  1. 1
    Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review. systematic review or meta-analysis; evidence still limited PubMed 25257544 DOI 10.1111/bph.12944
  2. 2
    SKNY-1, a THCV Analog, Produces Weight Loss, Lipid Normalization and Attenuation of Reward-Associated Behaviors in an mc4r(G894C) Zebrafish Model of Obesity. cell or laboratory study; mechanism-focused research PubMed 42196303 DOI 10.3390/ijms27104321
  3. 3
    It Is Our Turn to Get Cannabis High: Put Cannabinoids in Food and Health Baskets. narrative or expert review; evidence still limited PubMed 32899626 DOI 10.3390/molecules25184036
  4. 4
    Neural effects of cannabinoid CB1 neutral antagonist tetrahydrocannabivarin on food reward and aversion in healthy volunteers. clinical study in people; mechanism-focused research PubMed 25542687 DOI 10.1093/ijnp/pyu094
  5. 5
    Molecular Pharmacology of Phytocannabinoids. narrative or expert review; evidence still limited PubMed 28120231 DOI 10.1007/978-3-319-45541-9_3
  6. 6
    Pharmacology of cannabinoids in the treatment of epilepsy. narrative or expert review; evidence still limited PubMed 28087250 DOI 10.1016/j.yebeh.2016.11.016
  7. 7
    Phytocannabinoids as Novel SGLT2 Modulators for Renal Glucose Reabsorption in Type 2 Diabetes Management. narrative or expert review; evidence still limited PubMed 40872492 DOI 10.3390/ph18081101
  8. 8
    The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. narrative or expert review; evidence still limited PubMed 17828291 DOI 10.1038/sj.bjp.0707442
  9. 9
    Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation. animal study; mechanism-focused research PubMed 21726418 DOI 10.1111/j.1748-1716.2011.02338.x
  10. 10
    Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. animal study; mechanism-focused research PubMed 21175579 DOI 10.1111/j.1476-5381.2010.01166.x
  11. 11
    Effects of non-euphoric plant cannabinoids on muscle quality and performance of dystrophic mdx mice. animal study; mechanism-focused research PubMed 30074247 DOI 10.1111/bph.14460
  12. 12
    Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ(9) -tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats. animal study; mechanism-focused research PubMed 23902479 DOI 10.1111/bph.12322
See all 23 research sources

This complete source list is the deeper research layer for the page. Study type and evidence context are shown when they are available in the current record.

  1. It Is Our Turn to Get Cannabis High: Put Cannabinoids in Food and Health Baskets. narrative or expert review; evidence still limited / 1 linked research note PubMed 32899626
  2. SKNY-1, a THCV Analog, Produces Weight Loss, Lipid Normalization and Attenuation of Reward-Associated Behaviors in an mc4r(G894C) Zebrafish Model of Obesity. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 42196303
  3. Phytocannabinoids as Novel SGLT2 Modulators for Renal Glucose Reabsorption in Type 2 Diabetes Management. narrative or expert review; evidence still limited / 1 linked research note PubMed 40872492
  4. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. narrative or expert review; evidence still limited / 1 linked research note PubMed 17828291
  5. Pure Δ9-tetrahydrocannabivarin and a Cannabis sativa extract with high content in Δ9-tetrahydrocannabivarin inhibit nitrite production in murine peritoneal macrophages. animal study; mechanism-focused research / 1 linked research note PubMed 27498155
  6. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. animal study; mechanism-focused research / 1 linked research note PubMed 21175579
  7. Molecular Pharmacology of Phytocannabinoids. narrative or expert review; evidence still limited / 1 linked research note PubMed 28120231
  8. Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review. systematic review or meta-analysis; evidence still limited / 1 linked research note PubMed 25257544
  9. Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist. animal study; mechanism-focused research / 1 linked research note PubMed 16205722
  10. Pharmacology of cannabinoids in the treatment of epilepsy. narrative or expert review; evidence still limited / 1 linked research note PubMed 28087250
  11. Tetrahydrocannabivarin (THCV) Dose Dependently Blocks or Substitutes for Tetrahydrocannabinol (THC) in a Drug Discrimination Task in Rats. animal study; mechanism-focused research / 1 linked research note PubMed 41008636
  12. Δ9-tetrahydrocannabivarin impairs epithelial calcium transport through inhibition of TRPV5 and TRPV6. mechanism-focused research / 1 linked research note PubMed 30170189
  13. Δ8 -Tetrahydrocannabivarin has potent anti-nicotine effects in several rodent models of nicotine dependence. animal study; mechanism-focused research / 1 linked research note PubMed 31454413
  14. The plant cannabinoid Delta9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice. animal study; mechanism-focused research / 1 linked research note PubMed 20590571
  15. The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo. animal study; mechanism-focused research / 1 linked research note PubMed 17245367
  16. Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ(9) -tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats. animal study; mechanism-focused research / 1 linked research note PubMed 23902479
  17. The phytocannabinoid Delta(9)-tetrahydrocannabivarin modulates inhibitory neurotransmission in the cerebellum. animal study; mechanism-focused research / 1 linked research note PubMed 18311186
  18. Neural effects of cannabinoid CB1 neutral antagonist tetrahydrocannabivarin on food reward and aversion in healthy volunteers. clinical study in people; mechanism-focused research / 1 linked research note PubMed 25542687
  19. TRPV3 activation by different agonists accompanied by lipid dissociation from the vanilloid site. mechanism-focused research / 1 linked research note PubMed 38691614
  20. Loratadine, an antihistaminic drug, suppresses the proliferation of endometrial stromal cells by inhibition of TRPV2. animal study; mechanism-focused research / 1 linked research note PubMed 35714693
  21. Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation. animal study; mechanism-focused research / 1 linked research note PubMed 21726418
  22. An Evaluation of Understudied Phytocannabinoids and Their Effects in Two Neuronal Models. mechanism-focused research / 1 linked research note PubMed 34500785
  23. Effects of non-euphoric plant cannabinoids on muscle quality and performance of dystrophic mdx mice. animal study; mechanism-focused research / 1 linked research note PubMed 30074247